https://www.taxtmi.com/caselaws?id=84833 Notification No. 161/66 allows patents and proprietary medicines to be assessed on the declared retail price after a 25% discount, provided the price list reflects the price at which the medicines are ordinarily sold to consumers. Where the retail price is clearly specified, prominently printed, and the goods are sold at that declared price, the benefit of the notification applies. On those facts, denial of the valuation benefit is not sustainable and the exemption is available. en-us Mon, 28 Aug 1995 00:00:00 +0530 Mon, 01 Aug 2011 10:46:33 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=84833 Notification No. 161/66 allows patents and proprietary medicines to be assessed on the declared retail price after a 25% discount, provided the price list reflects the price at which the medicines are ordinarily sold to consumers. Where the retail price is clearly specified, prominently printed, and the goods are sold at that declared price, the benefit of the notification applies. On those facts, denial of the valuation benefit is not sustainable and the exemption is available. Case-Laws Central Excise Mon, 28 Aug 1995 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=84833